Status:
UNKNOWN
Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide
Lead Sponsor:
Bispebjerg Hospital
Conditions:
Asthma, Bronchial
Allergic Rhinitis
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the immunomodulatory effect of treatment of allergic rhinitis symptoms with specific immunotherapy by measurement of pulmonary inflammatory markers, and among ...
Eligibility Criteria
Inclusion
- Age 18-45 years old
- Skin prick test or RAS test and physical examination conclude that the patient will have a beneficial effect from specific immunotherapy
Exclusion
- Other diseases except atopic disease
- Pregnancy
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00312312
Start Date
March 1 2006
End Date
December 1 2008
Last Update
June 12 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg Hospital
Copenhagen, Denmark, 2400 NV